Advertisement
New Zealand markets closed

  • NZX 50

    11,717.43
    -117.59 (-0.99%)
     

  • NZD/USD

    0.6093
    +0.0009 (+0.15%)
     

  • NZD/EUR

    0.5680
    +0.0002 (+0.04%)
     

  • ALL ORDS

    8,013.80
    +11.00 (+0.14%)
     

  • ASX 200

    7,767.50
    +7.90 (+0.10%)
     

  • OIL

    81.46
    -0.28 (-0.34%)
     

  • GOLD

    2,336.90
    +0.30 (+0.01%)
     

  • NASDAQ

    19,682.87
    -106.16 (-0.54%)
     

  • FTSE

    8,164.12
    -15.56 (-0.19%)
     

  • Dow Jones

    39,118.86
    -45.20 (-0.12%)
     

  • DAX

    18,235.45
    +24.90 (+0.14%)
     

  • Hang Seng

    17,718.61
    +2.14 (+0.01%)
     

  • NIKKEI 225

    39,583.08
    +241.54 (+0.61%)
     

  • NZD/JPY

    97.9940
    +0.2610 (+0.27%)
     

Company News for Jun 24, 2024

Zacks Equity Research
·1-min read

  • FactSet Research Systems Inc.’s (FDS) shares surged 3.8% after posting third-quarter fiscal 2024 adjusted earnings per share of $4.37, surpassing the Zacks Consensus Estimate of $3.91.

  • Shares of Sarepta Therapeutics Inc. (SRPT) soared 30.1% following FDA’s approval for the expanded use of its gene therapy, Elevidys, for patients with Duchenne muscular dystrophy.

  • Hertz Global Holdings Inc.’s (HTZ) shares jumped 16% after the company raised the size of bond offerings from $750 million to $1 billion.

  • Shares of Asana Inc. (ASAN) climbed 15.3% after the company announced a share buyback program of $150 million likely to be wrapped up on Jun 30, 2025.  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Hertz Global Holdings, Inc. (HTZ) : Free Stock Analysis Report

FactSet Research Systems Inc. (FDS) : Free Stock Analysis Report

Sarepta Therapeutics, Inc. (SRPT) : Free Stock Analysis Report

Asana, Inc. (ASAN) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research